Unisem Agritech Ltd IPO GMP Today: Steady at ₹0; Expected Flat Listing
Unisem Agritech Ltd IPO Grey Market Premium analysis with subscription status, expected listing gain, and investor verdict.
Unisem Agritech Ltd IPO is approaching its listing on 2025-12-17 with muted sentiment in the unlisted arena. As the allotment is finalized today, investors are closely watching for any last-minute shifts in the Grey Market Premium (GMP).
📊 GMP Snapshot: What’s the Premium Today?
As of December 15, 2025, the grey market sentiment for Unisem Agritech Ltd remains flat. Market data indicates no premium over the issue price, suggesting a quiet debut on the bourses.
| Metric | Value |
|---|---|
| Issue Price | ₹65 |
| Current GMP | ₹0 (Source: ipowatch.in as of 2025-12-15) |
| Expected Listing Price | ₹65 |
| Expected Listing Gain | 0% |
| Minimum Investment | ₹130,000 (2000 shares) |
| Data Source | ipowatch.in / univest.in |
Note: The GMP has remained steady at ₹0 for the past three sessions, indicating a lack of speculative interest or aggressive buying in the unofficial market.
📈 Subscription Status: How Strong is the Demand?
The subscription window, which closed on December 12, 2025, saw a lukewarm response from investors. The issue was subscribed just 2.03 times overall, a figure significantly lower than recent SME IPO averages which often see subscription levels exceeding 50x.
| Category | Subscription |
|---|---|
| QIB | 1.79 times |
| NII | 1.78 times |
| Retail | 2.28 times |
| Overall | 2.03 times |
Interpretation: The subscription data reveals cautious sentiment across all categories. Retail investors showed slightly more interest (2.28x) than High Net-worth Individuals (NII) and Qualified Institutional Buyers (QIB), but the lack of heavy oversubscription—particularly from the NII segment—often correlates with weak listing day momentum.
🏢 Company Overview
Unisem Agritech Ltd operates in the agricultural sector, specializing in the processing and supply of hybrid seeds for vegetables, flowers, and field crops. The company leverages a network of dealers to distribute its products across various states.
Financial Performance:
- Revenue: Rose to ₹69.08 Cr in FY25 (up ~13% from ₹61.16 Cr in FY24).
- Profit After Tax (PAT): Surged to ₹4.27 Cr in FY25 (up ~98% from ₹2.15 Cr in FY24).
- Valuation: The issue is priced at a P/E ratio that reflects its growth trajectory, but the sector is highly competitive and subject to seasonal risks.
Despite the strong growth in bottom-line numbers, the market seems hesitant, likely due to the competitive nature of the hybrid seed industry and the broader cooling of the SME IPO segment.
🎯 Verdict: Should You Apply?
Based on the final subscription numbers and the current GMP trend, the listing outlook appears flat.
Verdict: Long Term Only
While the listing gain potential is currently negligible (0%), the company’s fundamentals show promise with a near doubling of profits in FY25. The lack of a “pop” in the grey market suggests that short-term flippers should stay away. However, for investors with a high-risk appetite and a multi-year horizon, the stock may offer value if the company sustains its current growth rate post-listing.
- For Listing Gain Seekers: The 0% GMP and low subscription (2.03x) are clear signals to Avoid expecting immediate returns.
- For Long-Term Investors: The financial growth is a positive signal, but liquidity in SME stocks can be low. Enter only if you are comfortable holding through volatility.
Disclaimer: This analysis is for informational purposes only and does not constitute financial advice. GMP is an unofficial indicator and may change rapidly.
Methodology & Disclosure
This market report is generated by Positune's Algorithmic Intelligence Engine. It aggregates real-time NSE data and verified news sources to provide instant market insights. While we verify facts via "Grounding" technology, this is automated analysis.
Compliance Notice: We are NOT SEBI-registered Investment Advisors or Research Analysts. The information provided is for educational purposes only and should not be construed as financial advice. Trading in the stock market involves risk. Please consult a qualified financial expert before making investment decisions.